Filbrandt Wealth Management’s Genmab GMAB Stock Holding History

Filbrandt Wealth Management’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-10	Closed	–	–	234
2020 Q2	$0	Buy	+10	New	+$273	﹤0.01%	416

Other funds holding GMAB

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Filbrandt Wealth Management's GMAB Position: Q3 2020 in Review

Filbrandt Wealth Management sold out of Genmab (GMAB) in Q3 2020, closing a stake of 10 shares.

Filbrandt Wealth Management first reported a position in GMAB in Q2 2020 and held it in 1 quarter. The position peaked at $0 in Q2 2020. 198 funds tracked by Wall St. Rank hold GMAB as of Q3 2020.

Filbrandt Wealth Management reported no remaining Genmab position as of Q3 2020 after selling out during the quarter.
Filbrandt Wealth Management sold 10 Genmab shares in Q3 2020.
Filbrandt Wealth Management first reported a position in Genmab in Q2 2020 and held it in 1 quarter.
Filbrandt Wealth Management's Genmab position peaked at $0 in Q2 2020.
198 funds tracked by Wall St. Rank held Genmab as of Q3 2020.

Based on Filbrandt Wealth Management's 13F filing for Q3 2020, filed 29 Oct 2020.